About Point of Care DiagnosticsPoint of Care Diagnostics (POCD) are specialists in patient-side medical diagnostics. Clinical testing is used for 70 percent of healthcare decisions and can help provide more targeted therapy at a lower cost. Point Of Care Diagnostics Market Opportunities and Technology Trends: The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. Cambridge Healthtech Institute’s 10th Annual Point-of-Care Diagnostics meeting will review the latest technological advances, such as microfluidics, nanosensors, and miniaturized devices; as well as integration of POCT in hospitals, pharmacies, critical and home care, mobile settings, and resource-limited settings. The Global Point-of-Care Diagnostics Market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028. Diagnostics has emerged as one of the largest and fastest growing segments with evolving diseases. The ‘Point-of-Care Diagnostics Market’ study added by Reports web, exhibits a comprehensive analysis of the growth trends present in the global business scenario. Point-of-care diagnostics (POCDs) are diagnostic tests that can be administered anywhere that a patient or consumer is receiving care. Australia. The segment has played a vital role in diagnosing growing and aging global population with increasing health expenditure and more prevalent lifestyle ailments including obesity, cancer, and cardiovascular diseases. Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care. The device is based on Atomo Diagnostics' existing point-of-care technology and will utilize cardiac markers developed by Brisbane-based Anteo Technologies. The healthcare system is changing, with a greater focus on value, reducing errors and giving more cost-effective care … POCD supply premium point of care testing devices and consumables for primary health and chronic care across Australia and New Zealand. Founded 2010. Visiongain’s study is for everybody needing commercial analyses for the Point of Care Diagnostics market and leading companies. The … Home care/self-testing commanded the largest share of the global point of care diagnostics market, owing to the mounting inclination for at-home healthcare, growing focus on continuous and remote monitoring, and expanding need for rapid tests among home care users. Pune, India, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The global Point of Care Diagnostics Market size is expected to reach USD 23.36 billion by 2027, exhibiting a … Chapter 6 provides information on nearly 280 point-of-care diagnostics that are either available or being developed for the diagnosis of respiratory infections, and a … However, some companies are on track to deliver the promise of high-plex, rapid molecular diagnostics at the point-of-care in the coming years and are introduced in the report. The holy grail of diagnostics would be a small box able to perform any kind of test in minutes. Global point of care diagnostics market size 2015-2022; Global point of care diagnostic market revenue 2015 and 2021 by country This study identifies the shift from conventional testing methods to rapid diagnostics as one of the prime reasons driving the point of care diagnostics … Point-of-Care Diagnostics Market … 10 Europe Point of Care Diagnostics – Company Profiles 10.1 … Global Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Product Technologies and platforms are being optimized for speed and reliability in a variety of settings, including bedside, resource-limited and pharmacy testing. The global point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4%. Point of Care Molecular Diagnostics Market is poised to value over USD 1.7 billion by 2027 end at a CAGR of over 14.5% during the forecast period 2020 to 2027 FutureWise Market Research has instantiated a report that provides an intricate analysis of Point of Care Molecular Diagnostics Market trends that shall affect the overall market growth. The report on the point of care diagnostics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. Atomo Diagnostics Pty Ltd. Show Similar Companies. Top 50 Companies in Point-of-Care Diagnostic Testing 2017 with Size and Growth of the Point-of-Care Diagnostics Market, 2016-2021 - Research and Markets News provided by Research and Markets Point of Care Diagnostics Market to Exhibit a Decent CAGR of 7.3% and Hit USD 23.36 Billion by 2027; Increasing Cases of Acute Diseases to Spur Sales Opportunities, states Fortune Business Insights™ Top 20 Diagnostics Companies Based On 2018 Revenue With the era of growing diseases, Diagnostics have played a vital role in diagnosing multiple diseases and disorders. Global Point Of Care Diagnostics Market: Geographical Segmentation Based on geography, the key segments reviewed in the research report are Asia Pacific, Europe, North America, and Rest of the World. 9 Europe Point of Care Diagnostics – Competitive Landscape 9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements 9.2 Market Share Analysis 9.3 Strategies Adopted By Top Companies. The point-of-care diagnostic market is expected to reach over $38 billion by 2022, and for good reason – POC diagnostics are quicker and more efficient, can eliminate follow up visits, can reach communities without access to major medical facilities, and save money in the healthcare system. The global Point-of-Care Diagnostics market size is projected to reach US$ 33460 million by 2026, from US$ 24030 million in 2020, at a CAGR of 5.7% during 2021-2026. The Point of Care Diagnostics Market 2020-2030 report will be of value to anyone who wants to better understand the market and its various segments. In the point-of-care (POC) diagnostics market, companies large and small are striving to develop new technologies that allow healthcare providers to rapidly diagnose patients, independent of location. You will find data, trends and predictions. Cambridge Healthtech Institute’s 5th Annual Point-of-Care Diagnostics Disrupting Healthcare Delivery 20-21 May 2020. The in vitro diagnostics market continues to attract the interest of investors and healthcare providers alike. The Global point-of-care diagnostics Market is segmented on the basis of type, application, and geography. Developing a prototype device for the early detection of heart damage, which is crucial to saving patients lives. Point-of-care diagnostics is one of the fastest moving segments of the diagnostics market, and innovations in sensors, microfluidics and smartphone technologies are allowing faster and more accurate diagnosis and monitoring of disease. The point of care diagnostics market analysis includes the product, end-user, and geography landscape. The global point-of-care (POC) diagnostics market size was USD 18.45 billion in 2019 and is projected to reach USD 23.36 billion by 2027, exhibiting a CAGR of 7.3% during the forecast period. We are agents for many innovative technologies that are shaping and changing health management in Australasia. The global infectious disease point-of-care (POC) diagnostics market size was USD 1,246.5 million in 2019 and is projected to reach USD 3,371.1 million by 2027, … U.S. point of care diagnostics and testing market size 2015-2022 Forecast of global point of care diagnostics market value 2015 and 2021 by region Diagnostics … Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, growing government support, and a dearth of skilled laboratory technicians are the major factors driving the growth of this market. The market for point-of-care diagnostics is projected to surpass $38 billion by 2022, and rapid testing is changing the paradigm for clinical care across many disease areas. This statistic depicts the size of the U.S. Global Point-of-Care Diagnostics Scope and Segment The global Point-of-Care Diagnostics market is segmented by company, region (country), by Type, and by Application.